Journal Article DKFZ-2026-02425

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Co-expression of non-signaling CARs enhances EGFRvIII-specific CAR T-cell cytotoxicity against head and neck squamous cell carcinoma.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
BioMed Central London

BMC cancer 26(1), 1149 () [10.1186/s12885-026-17058-z]
 GO

Abstract: Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat due to heterogeneous antigen expression and an immunosuppressive tumor microenvironment. The epidermal growth factor receptor variant III (EGFRvIII) is a tumor-specific splice form with no detectable protein expression in normal tissues. Nevertheless, its low and often heterogeneous expression in HNSCC has limited its utility as target antigen for immunological therapies using chimeric antigen receptor (CAR) T-cells. In contrast, full-length EGFR is frequently overexpressed in HNSCC, but its expression in normal tissues prevents its use as a directly activating CAR target. Thus, we investigated here whether EGFR can instead provide additional target antigen engagement as a non-signaling CAR (nsCAR) for EGFRvIII CARs. The nsCAR was derived from Cetuximab, an EGFR-binding monoclonal antibody whose epitope is retained in EGFRvIII and was co-expressed with different EGFRvIII-specific signaling CAR to investigate whether additional receptor engagement could enhance target-cell recognition and cytotoxicity.Primary human T-cells were engineered to express EGFRvIII-specific CARs alone or in combination with EGFR-directed nsCARs. Functional activity was evaluated using in vitro cytotoxicity assays, time-resolved killing dynamics, and fluorescence microscopy to assess immunological synapse (IS) formation in HNSCC cell lines with defined levels of EGFRvIII expression.EGFRvIII CAR T-cells exhibited clear target antigen density-dependent cytotoxicity. Co-expression of the EGFR nsCAR specifically enhanced tumor cell killing in selected CAR and target antigen combinations, with the strongest effects observed under conditions of limited baseline CAR activity, whereas the nsCAR alone was non-cytotoxic. Fluorescence imaging revealed co-localization of CAR and nsCAR molecules at the T-cell-target-cell contact interface.EGFR nsCAR co-expression can provide a modular strategy to enhance EGFRvIII CAR T-cell cytotoxicity under conditions of limited target antigen availability. These findings provide an in vitro proof of concept for additional target engagement through a non-signaling receptor and warrant further evaluation in more complex preclinical models.

Keyword(s): Humans (MeSH) ; ErbB Receptors: immunology (MeSH) ; ErbB Receptors: metabolism (MeSH) ; ErbB Receptors: genetics (MeSH) ; Receptors, Chimeric Antigen: immunology (MeSH) ; Receptors, Chimeric Antigen: genetics (MeSH) ; Receptors, Chimeric Antigen: metabolism (MeSH) ; Squamous Cell Carcinoma of Head and Neck: immunology (MeSH) ; Squamous Cell Carcinoma of Head and Neck: therapy (MeSH) ; Squamous Cell Carcinoma of Head and Neck: metabolism (MeSH) ; Head and Neck Neoplasms: immunology (MeSH) ; Head and Neck Neoplasms: therapy (MeSH) ; Immunotherapy, Adoptive: methods (MeSH) ; Cell Line, Tumor (MeSH) ; T-Lymphocytes: immunology (MeSH) ; T-Lymphocytes: metabolism (MeSH) ; Cytotoxicity, Immunologic (MeSH) ; Cetuximab (MeSH) ; Receptors, Antigen, T-Cell (MeSH) ; Signal Transduction (MeSH) ; Antigen density ; CAR T-cell therapy ; Dual-epitope engagement ; EGFRvIII ; HNSCC ; Immunotherapy ; Non-signaling CAR ; Tumor-specific antigen (TSA) ; ErbB Receptors ; Receptors, Chimeric Antigen ; epidermal growth factor receptor VIII ; Cetuximab ; Receptors, Antigen, T-Cell

Classification:

Note: #EA:D270#

Contributing Institute(s):
  1. NWG Pädriatische Immunonkologie (D270)
Research Program(s):
  1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2026
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-10-01, last modified 2026-10-02


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)